Global Point-of-Care Testing Market to Touch USD 30 Bn by 2022, States RNCOS in Its New Topical Report Recently Published at MarketPublishers.com
23 Dec 2016 • by Natalie Aster
LONDON – Worldwide, the point-of-care testing market is set to grow at an immensely fast pace in the nearest future, majorly owing to the increasing adoption of point-of-care tests from pole to pole across various medical conditions, high potential to improve global health and also to cut public and national expenditures on healthcare as well as owing to enhancing usage in the field of critical care settings to deliver decentralized and patient-centric care.
Through 2022, the worldwide point-of-care testing market is anticipated to reach the value of about USD 30 billion.
At present, the glucose monitoring kits segment captures the largest share of the overall point-of-care market. This is attributed to increasing prevalence of diabetes and also remarkable technological advancements in the blood glucose self-monitoring devices sector.
Geography-wise, North America ranks the top regional market for point-of-care testing.
New insightful research publication “Global Point of Care Testing Market, by Product, Outlook 2022” drawn up by RNCOS E-Services provides an unbiased analysis of the ongoing and projected performance of the world point-of-care testing market.
The report reviews the market dynamics, examines the major market growth drivers and challenges, provides an insight into the latest and future possible market trends and developments. Future growth opportunities are also discussed in the research report along with data on competitive landscape and the most prominent participants in the world point-of-care testing market. This study offers an overview of the latest product launches and the recent industry developments. A future holistic outlook for the global point-of-care testing market through 2022 is available here, too.
Many other market research publications by RNCOS E-Services are presented at the publisher's page at MarketPublishers.com.